1-6 of 6
Bertold Emmerich, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG)

Manuela A. Bergmann, MD, Raymonde Busch, PhD, Barbara Eichhorst, MD, Andreas Buehler, MD, Norbert Fischer, MD, Michael J Eckart, MD, Ursula Vehling-Kaiser, MD, Ulrich Jäger, MD, Georg Hopfinger, MD, Clemens Wendtner, MD, Kirsten Fischer, MD, Bertold Emmerich, MD, Hartmut Döhner, MD, Michael Hallek, M.D. Ph.D., Stephan Stilgenbauer, MD
Journal: Blood
Blood (2013) 122 (21): 4127.
https://doi.org/10.1182/blood.V122.21.4127.4127
Published: 2013
Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Christian Straka, MD, PhD, Peter Liebisch, MD, Burkhard Hennemann, MD, Bernd Metzner, MD, Hans Salwender, MD, Lothar Kanz, MD, PhD, Sigrid Adler-Reichel, MD, Wolf-Dieter Ludwig, MD, PhD, Hannes Wandt, MD, PhD, Martin Bentz, MD, PhD, Tim Bruemmendorf, MD, PhD, Markus Hentrich, MD, Lorenz Truemper, MD, PhD, Mathias Freund, MD, PhD, Hans-Heinrich Wolf, MD, Sezer Orhan, MD, PhD, Ralf Bargou, MD, PhD, Gottfried Doelken, MD, PhD, Norbert Schmitz, MD, PhD, Helga Bernhard, MD, PhD, Martin Gramatzki, MD, PhD, Norbert Frickhofen, MD, PhD, Helmut Ostermann, MD, PhD, Ralf Schmidmaier, MD, Stefan Ibach, PhD, Axel Hinke, PhD, Hermann Einsele, MD, PhD, Bertold Emmerich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 446.
https://doi.org/10.1182/blood.V110.11.446.446
Published: 2007
Journal Articles

17p Deletion Predicts for Inferior Overall Survival after Fludarabine - Based First Line Therapy in Chronic Lymphocytic Leukemia: First Analysis of Genetics in the CLL4 Trial of the GCLLSG.

Stephan Stilgenbauer, MD, Alexander Kröber, MD, Raymonde Busch, PhD, Barabara Eichhorst, MD, Dirk Kienle, MD, Dirk Winkler, MD, Georg Hopfinger, MD, Peter Lichter, MD, Bertold Emmerich, MD, Michael Hallek, MD, Hartmut Döhner, MD, The GCLLSG
Journal: Blood
Blood (2005) 106 (11): 715.
https://doi.org/10.1182/blood.V106.11.715.715
Published: 2005
Journal Articles

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Tanja Lahaye, MD, Oliver G. Ottmann, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Ulrike Haus, Rudiger Hehlmann, MD, Anthony D. Ho, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2005) 106 (11): 1105.
https://doi.org/10.1182/blood.V106.11.1105.1105
Published: 2005
Journal Articles

Higher Expression Levels of the Adhesion Molecules VLA-4 and ICAM-1 on Multiple Myeloma Cells after Chemotherapy Are Associated with Survival of a Multidrug Resistant Subpopulation in Vivo.

Ralf Schmidmaier, MD, Kerstin Mörsdorf, Philipp Baumann, Bertold Emmerich, MD, Gerold Meinhardt, MD
Journal: Blood
Blood (2004) 104 (11): 4866.
https://doi.org/10.1182/blood.V104.11.4866.4866
Published: 2004
Journal Articles

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Harald Gschaidmeier, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2004) 104 (11): 2929.
https://doi.org/10.1182/blood.V104.11.2929.2929
Published: 2004